NoaKrugliakClevelandMD

Inflammatory Bowel Disease

Physician

Dr. Cleveland is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

Dose escalation of biologics in biologic-naive patients with Crohn's disease: Outcomes from the ODESSA-CD study.
Noa Krugliak Cleveland, Sabyasachi Ghosh, Niranjan Kathe, Kandavadivu Umashankar, Kirti Mirchandani
Journal of Managed Care & Specialty Pharmacy. 2024-11-01
5 citations
Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY.
Noa Krugliak Cleveland, Sabyasachi Ghosh, Benjamin Chastek, Tim Bancroft, Ninfa Candela
Inflammatory Bowel Diseases. 2024-10-03
Real-World Treatment Outcomes Associated With Early Versus Delayed Vedolizumab Initiation in Patients With Ulcerative Colitis.
Noa Krugliak Cleveland, Ninfa Candela, John A Carter, Maja Kuharic, Joyce Qian
Crohn's & Colitis 360. 2024-10-01

Assessment of Peri-Polyp Biopsy Specimens of Flat Mucosa in Patients with Inflammatory Bowel DiseaseApril 2018
Assessment of Peri-Polyp Biopsies of Flat Mucosa in Patients with Inflammatory Bowel DiseaseJanuary 2018

UChicago Medicine Trains Physicians on ‘Game-Changing’ Intestinal UltrasoundMarch 8th, 2023
Ultrasound Monitoring of IBD May Prompt Faster Treatment ChangeJanuary 26th, 2024